UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State or other jurisdiction of |
|
(Commission |
|
(I.R.S. Employer |
|
Incorporation or Organization) |
|
File Number) |
|
Identification No.) |
(Address of principal executive office) (Zip Code)
Registrant’s telephone number, including area code (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On August 11, 2021, Universal Health Services, Inc. issued a press release announcing the pricing of a private offering of $700 million aggregate principal amount of its 1.650% senior secured notes due 2026 and $500 million aggregate principal amount of its 2.650% senior secured notes due 2032. A copy of a press release is attached hereto as Exhibit 99.1.
The information contained in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
|
|
|
|
|
99.1 |
|
Universal Health Services, Inc., press release, dated August 11, 2021. |
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Universal Health Services, Inc. |
||
|
|
||
|
By: |
|
/s/ Steve Filton |
|
Name: Steve Filton |
||
|
Title: Executive Vice President and Chief Financial Officer |
||
Date: August 11, 2021
Exhibit 99.1
FOR IMMEDIATE RELEASE
August 11, 2021
|
CONTACT: |
Steve Filton |
|
|
Chief Financial Officer |
|
|
610-768-3300 |
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES PRICING OF
SENIOR SECURED NOTES OFFERING
KING OF PRUSSIA, PA – Universal Health Services, Inc. (NYSE: UHS) announced the pricing of its previously announced private offering of senior secured notes. The Company priced the offering of $700 million aggregate principal amount of its 1.650% senior secured notes due 2026 (the “2026 Notes”) and $500 million aggregate principal amount of its 2.650% senior secured notes due 2032 (the “2032 Notes”, and together with the 2026 Notes, the “Notes”). The Notes will pay interest semi-annually in arrears, on March 1 and September 1 of each year, beginning on March 1, 2022 for the 2026 Notes and on January 15 and July 15 of each year, beginning on January 15, 2022 for the 2032 Notes. The 2026 Notes will mature on September 1, 2026 and the 2032 Notes will mature on January 15, 2032, unless earlier redeemed or repurchased. The Notes offering is expected to close on August 24, 2021, subject to customary closing conditions.
The Company intends to use the net proceeds of the offering to redeem all of the outstanding $400 million aggregate principal amount of its 5.00% Senior Secured Notes due 2026 (the “Existing 2026 Notes”) on or about September 13, 2021, to pay accrued and unpaid interest on the Existing 2026 Notes to but excluding the date of redemption, to repay certain indebtedness under its senior credit facility, to pay transaction expenses and for general corporate purposes.
The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities law and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable state securities laws. The Notes will be offered only to persons reasonably believed to be qualified institutional buyers under Rule 144A of the Securities Act and outside the United States under Regulation S of the Securities Act.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any offers of the Notes will be made only by means of a private offering memorandum. This notice is being issued pursuant to and in accordance with Rule 135(c) under the Securities Act.
Certain statements in this release may constitute forward-looking statements and are subject to various risks and uncertainties as discussed in the Company’s filings with the Securities and Exchange Commission. The Company is not obligated to update these forward-looking statements even if the Company’s assessment of these risks and uncertainties changes.
Universal Health Services, Inc. (“UHS”) is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.